OncoSynergy, Inc.

A patient-focused, clinical-stage immuno-oncology startup. Our lead candidate, #OS2966, is FDA Orphan Drug Designated for glioblastoma and ovarian cancer.

[OncoSynergy, Inc. @OncoSynergy]

Congrats @EKNduom 🎉! We are excited to continue collaborating on impactful research with you.

[Edjah Nduom, MD (he/him) @EKNduom]

I am honored to announce that I was awarded the Daniel Louis Barrow Endowed Chair in Neurosurgery @emoryneurosurgery. I would like to thank my family, my mentors and mentees, colleagues, friends, and the philanthropic support that made this possible:

https://t.co/N23JBacG5H

[OncoSynergy, Inc. @OncoSynergy]

Congrats Chibueze! The entire OncoSynergy team is proud of you!

[OncoSynergy, Inc. @OncoSynergy]

“There is no limit to what we, as women, can accomplish.” - Michelle Obama

Happy International Women's Day from this woman-led company dedicated to treating rare and resistant cancers.

#internationalwomensday

[OncoSynergy, Inc. @OncoSynergy]

- (bottom right) Dr. Edith H. Quimby, a medical physicist, was a pioneer in the therapeutic use of X-rays and radium.

[OncoSynergy, Inc. @OncoSynergy]

Trailblazers 💫 #WomensHistoryMonth

Pictured:
- (top left) Dr. Jane C. Wright is known for promoting chemotherapy as a viable treatment option for patients.

[OncoSynergy, Inc. @OncoSynergy]

- (bottom left) Dr. Rosalind Franklin was a chemist and X-ray crystallographer whose Photo 51 revealed the double helix of DNA — an essential discovery in understanding DNA.

[OncoSynergy, Inc. @OncoSynergy]

To learn more about Dr. Cooke Wright, visit https://t.co/5pw8pv7B5b

[OncoSynergy, Inc. @OncoSynergy]

February is Black History Month and OncoSynergy would like to celebrate a pioneer in the oncology space - Dr. Jane Cooke Wright.

#BHM #BlackHistory #BlackHistoryMonth

[OncoSynergy, Inc. @OncoSynergy]

🧬 Was the Head of the Cancer Chemotherapy Department and Associate Dean at New York Medical College
🧬 Was the first woman to be elected President of the New York Cancer Society
🧬 Was appointed Head of the Cancer Research Foundation at the age of 33.

[OncoSynergy, Inc. @OncoSynergy]

Over 40% of cancers occur due to preventable causes ( i.e. poor diet, lack of exercise, smoking, sun overexposure). 🍔🌭🛋️🚬🚭☀️

During #NationalCancerPreventionMonth we urge you to make one lifestyle change that can reduce your cancer risk🎗️

[Brain Surgery Dropout @bigaxon]

Shout out to the team at @OncoSynergy for this accomplishment and our amazing collaborators at @ChildrensLA, led by Yong Mi Kim, MD, PhD.

https://t.co/V2OHk6d2Sk

[Brain Surgery Dropout @bigaxon]

When you realize the cancer drug you invented is a platform. 🤎💙

[OncoSynergy, Inc. @OncoSynergy]

Let us continue to strive towards a hopeful and just world. #MLKDay #MLKJRDAY #mlkjr

[OncoSynergy, Inc. @OncoSynergy]

"Based on that data from CHLA, the FDA granted OncoSynergy Inc. orphan drug designation for the compound, OS2966, a first-in-class monoclonal antibody that targets a protein called integrin beta-1."

Read more about this exciting work to treat #AML here: https://t.co/Diadqr58XW

[OncoSynergy, Inc. @OncoSynergy]

Happy New Year from OncoSynergy🧠🎆

[OncoSynergy, Inc. @OncoSynergy]

#MerryChristmas and Happy Holidays from the #OncoSynergy family to yours🎄💙